AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Explore various ways to save for a house purchase that can help you reach your financial goals. Start planning for your dream home!
9,837 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
PayPal stock has been grabbing headlines with a rapid rise tied to buyout chatter and a strategic turnaround. This gu...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
When Sony's leadership signals a fresh start for Spider-Man’s offshoot films, it’s not just a movie headline—it’s a l...
The crypto market has seen a meaningful pullback in 2026, creating potential bargains for patient investors. This gui...
As mortgage markets wobble in March 2026, Ninja Selling’s Larry Kendall champions a habit-first approach for loan off...
A large institutional stake in Enviri sparks questions about the company’s trajectory. This article breaks down what ...
As Berkshire Hathaway transitions from Buffett to Greg Abel, Abel makes a bold opening move. This piece explains the ...
A nationwide recall has been issued for nearly 90,000 bottles children's ibuprofen after reports of contamination. Fa...
With earnings on the horizon and a bold pivot to AI infrastructure, investors face a tough call. This guide breaks do...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
Supreme Lending adds a Houston-based team with over $100 million in annual loan production, strengthening its Texas f...